Suscribirse

Cooking birch pollen–related food: Divergent consequences for IgE- and T cell–mediated reactivity in vitro and in vivo - 17/08/11

Doi : 10.1016/j.jaci.2006.03.011 
Barbara Bohle, PhD a, , Bettina Zwölfer a, Annice Heratizadeh, MD b, Beatrice Jahn-Schmid, PhD a, Yuliya Dall Antonia, PhD c, Mareike Alter, MD b, Walter Keller, PhD c, Laurian Zuidmeer, PhD d, Ronald van Ree, PhD d, Thomas Werfel, MD b, Christof Ebner, MD e
a From the Department of Pathophysiology, Center for Physiology and Pathophysiology, Medical University of Vienna 
b Department of Dermatology and Allergology, Hannover Medical School, Hannover 
c Karl-Franzens University, Institute of Chemistry, Graz 
d Department of Experimental Immunology, Amsterdam Medical Centre, Amsterdam 
e Allergy Clinic Reumannplatz, Vienna 

Reprint requests: Barbara Bohle, PhD, Medical University of Vienna, Center for Physiology and Pathophysiology, Department of Pathophysiology, Waehringer Guertel 18-20, AKH-3Q A-1090 Wien, Austria.

Vienna and Graz, Austria, Hannover, Germany, and Amsterdam, The Netherlands

Abstract

Background

The major birch pollen allergen Bet v 1 cross-reacts with homologous food allergens, resulting in IgE-mediated oral allergy syndromes (OASs). To avoid this food, allergy allergologists and guidebooks advise patients to consume birch pollen–related foods after heating.

Objective

We sought to evaluate whether cooked Bet v 1–related food allergens induce IgE- and T cell–mediated reactions in vitro and in vivo.

Methods

Recombinant Bet v 1, Mal d 1 (apple), Api g 1 (celery), and Dau c 1 (carrot) were incubated at increasing temperatures. Protein structures were determined by means of circular dichroism. Mediator release was tested in basophil activation assays. PBMCs and Bet v 1–specific T-cell lines with known epitope specificity were stimulated with native and cooked food allergens. Patients with birch pollen allergy who experienced OAS and the exacerbation of atopic dermatitis (AD) on ingestion of fresh apple, celery, or carrot were retested in double-blind, placebo-controlled food challenges with the respective foods in cooked form.

Results

In vitro, cooked food allergens lost the capacity to bind IgE and to induce mediator release but had the same potency to activate Bet v 1–specific T cells as native proteins. In vivo, ingestion of cooked birch pollen–related foods did not induce OAS but caused atopic eczema to worsen.

Conclusion

T-cell cross-reactivity between Bet v 1 and related food allergens occurs independently of IgE cross-reactivity in vitro and in vivo. In patients with AD, the resulting immune reaction can even manifest as late eczematous skin reactions. Therefore the view that cooked pollen-related foods can be consumed without allergologic consequences should be reconsidered.

Clinical implications

Symptom-free consumed pollen-related food allergens might cause T cell–mediated late-phase skin reactions in patients with pollen allergy and AD.

El texto completo de este artículo está disponible en PDF.

Key words : Birch pollen allergy, food allergy, oral allergy syndrome, atopic dermatitis, pathogenesis-related protein family 10, Bet v 1, cross-reactivity

Abbreviations used : aa, AD, DBPCFC, OAS, PR-10, RBL, TCL, Tm


Esquema


 Supported by the Fonds zur Förderung der wissenschaftlichen Forschung (SFB-F1807-B04 to B. Bohle, F1805-B04 to W. Keller) and Biomay, Austria.
Disclosure of potential conflict of interest: R. van Ree has consultant arrangements with HAL Allergy BV, Stallergenes SA, and Ventria Bioscience and has received grants from HAL Allergy BV and Stallergenes SA. The rest of the authors have declared that they have no conflict of interest.


© 2006  American Academy of Allergy, Asthma and Immunology. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 118 - N° 1

P. 242-249 - juillet 2006 Regresar al número
Artículo precedente Artículo precedente
  • Activation of T cells by carbamazepine and carbamazepine metabolites
  • Ying Wu, Joseph P. Sanderson, John Farrell, Nicola S. Drummond, Anita Hanson, Elizabeth Bowkett, Neil Berry, Andrew V. Stachulski, Stephen E. Clarke, Werner J. Pichler, Munir Pirmohamed, B. Kevin Park, Dean J. Naisbitt
| Artículo siguiente Artículo siguiente
  • Predictive value of skin prick tests using recombinant allergens for diagnosis of peanut allergy
  • Catherine Astier, Martine Morisset, Olivier Roitel, Fanny Codreanu, Sandrine Jacquenet, Patricia Franck, Virginie Ogier, Nicolas Petit, Barbara Proust, Denise-Anne Moneret-Vautrin, A. Wesley Burks, Bernard Bihain, Hugh A. Sampson, Gisèle Kanny

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.